Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ

REFERENCES

• Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health and disease. Physiol. Rev. 90:859–904.
   PubMed Web of Science ®Google Scholar
• Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101:15718–15723.
   PubMed Web of Science ®Google Scholar
• Backhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104:979–984.
   PubMed Web of Science ®Google Scholar
• Lichtenstein L, Kersten S. 2010. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta 1801:415–420.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Shimizugawa T, Ono M, Furukawa H. 2002. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43:1770–1772.
   PubMed Web of Science ®Google Scholar
• Ge H, Yang G, Yu X, Pourbahrami T, Li C. 2004. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 45:2071–2079.
   PubMed Web of Science ®Google Scholar
• Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Fraser CC, Yang DD, Heuer JG, Jaskunas SR, Eacho P. 2005. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146:4943–4950.
   PubMed Web of Science ®Google Scholar
• Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S. 2006. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281:934–944.
   PubMed Web of Science ®Google Scholar
• Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW, Lam KS. 2005. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc. Natl. Acad. Sci. U. S. A. 102:6086–6091.
   PubMed Web of Science ®Google Scholar
• Yu X, Burgess SC, Ge H, Wong KK, Nassem RH, Garry DJ, Sherry AD, Malloy CR, Berger JP, Li C. 2005. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc. Natl. Acad. Sci. U. S. A. 102:1767–1772.
   PubMed Web of Science ®Google Scholar
• Georgiadi A, Lichtenstein L, Degenhardt T, Boekschoten MV, van Bilsen M, Desvergne B, Muller M, Kersten S. 2010. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ. Res. 106:1712–1721.
   PubMed Web of Science ®Google Scholar
• Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, van der Meer R, He Y, Qi L, Koster A, Tamsma JT, Tan NS, Muller M, Kersten S. 2010. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 12:580–592.
   PubMed Web of Science ®Google Scholar
• Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275:28488–28493.
   PubMed Web of Science ®Google Scholar
• Yoon JC, Chickering TW, Rosen ED, Dussault B, Qin Y, Soukas A, Friedman JM, Holmes WE, Spiegelman BM. 2000. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20:5343–5349.
   PubMed Web of Science ®Google Scholar
• Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M. 2007. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol. Genomics 30:192–204.
   PubMedGoogle Scholar
• Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F, Stefan N, Fritsche A, Haring HU. 2009. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58:579–589.
   PubMed Web of Science ®Google Scholar
• Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, Hesselink MK, Schrauwen P, Muller M. 2009. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 29:969–974.
   PubMed Web of Science ®Google Scholar
• Modica S, Gofflot F, Murzilli S, D'Orazio A, Salvatore L, Pellegrini F, Nicolucci A, Tognoni G, Copetti M, Valanzano R, Veschi S, Mariani-Costantini R, Palasciano G, Schoonjans K, Auwerx J, Moschetta A. 2010. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology 138:636–648.
   PubMed Web of Science ®Google Scholar
• Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2006. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789–799.
   PubMed Web of Science ®Google Scholar
• Aronsson L, Huang Y, Parini P, Korach-Andre M, Hakansson J, Gustafsson JA, Pettersson S, Arulampalam V, Rafter J. 2010. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5:e13087. doi:10.1371/journal.pone.0013087.
   PubMed Web of Science ®Google Scholar
• Siersbaek MS, Loft A, Aagaard MM, Nielsen R, Schmidt SF, Petrovic N, Nedergaard J, Mandrup S. 2012. Genome-wide profiling of peroxisome proliferator-activated receptor gamma in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Mol. Cell. Biol. 32:3452–3463.
   PubMed Web of Science ®Google Scholar
• Gijsbers L, Man HY, Kloet SK, de Haan LH, Keijer J, Rietjens IM, van der Burg B, Aarts JM. 2011. Stable reporter cell lines for peroxisome proliferator-activated receptor gamma (PPARgamma)-mediated modulation of gene expression. Anal. Biochem. 414:77–83.
   PubMedGoogle Scholar
• Sonneveld E, Riteco JA, Jansen HJ, Pieterse B, Brouwer A, Schoonen WG, van der Burg B. 2006. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol. Sci. 89:173–187.
   PubMed Web of Science ®Google Scholar
• Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B. 2005. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol. Sci. 83:136–148.
   PubMed Web of Science ®Google Scholar
• Koppen A, Houtman R, Pijnenburg D, Jeninga EH, Ruijtenbeek R, Kalkhoven E. 2009. Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor. Mol. Cell. Proteomics 8:2212–2226.
   PubMed Web of Science ®Google Scholar
• Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80. doi:10.1186/gb-2004-5-10-r80.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264.
   PubMed Web of Science ®Google Scholar
• Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F. 2005. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33:e175. doi:10.1093/nar/gni179.
   PubMed Web of Science ®Google Scholar
• Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rucker C. 2007. Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol. Pharmacol. 71:398–406.
   PubMedGoogle Scholar
• Dominguez C, Boelens R, Bonvin AM. 2003. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125:1731–1737.
   PubMed Web of Science ®Google Scholar
• Malapaka RR, Khoo S, Zhang J, Choi JH, Zhou XE, Xu Y, Gong Y, Li J, Yong EL, Chalmers MJ, Chang L, Resau JH, Griffin PR, Chen YE, Xu HE. 2012. Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors. J. Biol. Chem. 287:183–195.
   PubMed Web of Science ®Google Scholar
• de Vries SJ, van Dijk M, Bonvin AM. 2010. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 5:883–897.
   PubMed Web of Science ®Google Scholar
• Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905–921.
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Tirado-Rives J. 1988. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110:1657–1666.
   PubMed Web of Science ®Google Scholar
• Macfarlane GT, Gibson GR, Cummings JH. 1992. Comparison of fermentation reactions in different regions of the human colon. J. Appl. Bacteriol. 72:57–64.
   PubMedGoogle Scholar
• Boffa LC, Vidali G, Mann RS, Allfrey VG. 1978. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253:3364–3366.
   PubMed Web of Science ®Google Scholar
• Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. 2008. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 19:587–593.
   PubMed Web of Science ®Google Scholar
• Harmon GS, Dumlao DS, Ng DT, Barrett KE, Dennis EA, Dong H, Glass CK. 2010. Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. Nat. Med. 16:313–318.
   PubMed Web of Science ®Google Scholar
• Han X, Benight N, Osuntokun B, Loesch K, Frank SJ, Denson LA. 2007. Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis. Gut 56:73–81.
   PubMedGoogle Scholar
• Lee SK, Kim YW, Chi SG, Joo YS, Kim HJ. 2009. The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis. Digest. Dis. Sci. 54:255–263.
   PubMedGoogle Scholar
• Narravula S, Colgan SP. 2001. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 166:7543–7548.
   PubMed Web of Science ®Google Scholar
• Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A. 2002. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Gut 50:658–664.
   PubMed Web of Science ®Google Scholar
• Wang JB, Qi LL, Zheng SD, Wang HZ, Wu TX. 2009. Curcumin suppresses PPARdelta expression and related genes in HT-29 cells. World J. Gastroenterol. 15:1346–1352.
   PubMed Web of Science ®Google Scholar
• Kaddatz K, Adhikary T, Finkernagel F, Meissner W, Muller-Brusselbach S, Muller R. 2010. Transcriptional profiling identifies functional interactions of TGF beta and PPAR beta/delta signaling: synergistic induction of ANGPTL4 transcription. J. Biol. Chem. 285:29469–29479.
   PubMed Web of Science ®Google Scholar
• Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, Kleemann R, Bakker A, Veenman F, Wahli W, Muller M, Kersten S. 2004. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279:34411–34420.
   PubMed Web of Science ®Google Scholar
• Camirand A, Marie V, Rabelo R, Silva JE. 1998. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology 139:428–431.
   PubMed Web of Science ®Google Scholar
• Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, Leitinger N. 2007. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc. Biol. 27:1276–1282.
   PubMed Web of Science ®Google Scholar
• Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA. 1999. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48:1593–1599.
   PubMed Web of Science ®Google Scholar
• Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ. 2006. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55:1104–1113.
   PubMed Web of Science ®Google Scholar
• Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, Straus DS. 2005. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm. Bowel Dis. 11:231–243.
   PubMedGoogle Scholar
• Higgins LS, Depaoli AM. 2010. Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. Am. J. Clin. Nutr. 91:267S–272S.
   PubMedGoogle Scholar
• Guan HP, Ishizuka T, Chui PC, Lehrke M, Lazar MA. 2005. Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 19:453–461.
   PubMed Web of Science ®Google Scholar
• Yu C, Markan K, Temple KA, Deplewski D, Brady MJ, Cohen RN. 2005. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J. Biol. Chem. 280:13600–13605.
   PubMed Web of Science ®Google Scholar
• Rakhshandehroo M, Knoch B, Muller M, Kersten S. 2010. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010:612089. doi:10.1155/2010/612089.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Suzuki Y, Saito Y. 2002. Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. Biochem. Biophys. Res. Commun. 293:827–831.
   PubMed Web of Science ®Google Scholar
• Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schroder O. 2007. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling. Mol. Immunol. 44:3625–3632.
   PubMed Web of Science ®Google Scholar
• Georgiadi A, Kersten S. 2012. Mechanisms of gene regulation by fatty acids. Adv. Nutr. 3:127–134.
   PubMed Web of Science ®Google Scholar
• Bugaut M, Bentejac M. 1993. Biological effects of short-chain fatty acids in nonruminant mammals. Annu. Rev. Nutr. 13:217–241.
   PubMed Web of Science ®Google Scholar
• Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221–1227.
   PubMed Web of Science ®Google Scholar
• Dai Y, Wang WH. 2010. Peroxisome proliferator-activated receptor gamma and colorectal cancer. World J. Gastrointest. Oncol. 2:159–164.
   PubMed Web of Science ®Google Scholar
• Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. 2006. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55:1341–1349.
   PubMed Web of Science ®Google Scholar
• Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 5:104–112.
   PubMed Web of Science ®Google Scholar
• Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. 1999. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Investig. 104:383–389.
   PubMed Web of Science ®Google Scholar
• Meijer K, de Vos P, Priebe MG. 2010. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr. Opin. Clin. Nutr. Metab. Care 13:715–721.
   PubMed Web of Science ®Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27:104–119.
   PubMed Web of Science ®Google Scholar
• Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L, Lam CR, Yau YH, Tan CK, Huang RL, Tan SM, Tang MB, Ding JL, Kersten S, Tan NS. 2010. Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am. J. Pathol. 177:2791–2803.
   PubMed Web of Science ®Google Scholar
• Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L, Tan CK, Huang RL, Sze SK, Tang MB, Ding JL, Kersten S, Tan NS. 2010. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J. Biol. Chem. 285:32999–33009.
   PubMed Web of Science ®Google Scholar
• Sukonina V, Lookene A, Olivecrona T, Olivecrona G. 2006. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 103:17450–17455.
   PubMed Web of Science ®Google Scholar
• Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB. 2002. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415:813–817.
   PubMed Web of Science ®Google Scholar